What LDC graduation will mean for pharma industry

Domestic pharmaceutical companies say losing patent rights flexibilities will make medicines more expensive, as producing them would be costly.

Pharmaceutical companies in Nepal are allowed to produce medicines just by paying royalties to the innovators and without obtaining patent rights.